Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas

Yuchen Jiao(Chinese Academy of Medical Sciences & Peking Union Medical College), Laura D. Wood(Johns Hopkins University), Gregory J. Gores(Mayo Clinic in Arizona), Michele Simbolo(University of Verona), Victor E. Velculescu(Johns Hopkins University), Filippo de Braud(University of Milan), Andrea Mafficini(University of Verona), David S. Klimstra(Yale University), Florin M. Selaru(Sidney Kimmel Cancer Center), Andrea Ruzzenente(University of Verona), Irinel Popescu(Institutul Clinic Fundeni), Robert A. Anders(Johns Hopkins University), Simona Dima(Carol Davila University of Medicine and Pharmacy), Rachel Karchin(University of Baltimore), G. Johan A. Offerhaus(Amsterdam UMC Location University of Amsterdam), Nickolas Papadopoulos(Johns Hopkins University), Lewis R. Roberts(Mayo Clinic), Donald J. Lucas(Walter Reed National Military Medical Center), William R. Jarnagin(Memorial Sloan Kettering Cancer Center), Rita T. Lawlor(University of Verona), Matteo Fassan(University of Padua), Anirban Maitra(NYU Langone Health), Giampaolo Tortora(University of Naples Federico II), Juan Carlos Roa(Pontificia Universidad Católica de Chile), Violeta Beleva Guthrie(Johns Hopkins University), Timothy M. Pawlik(The Ohio State University), Kenneth W. Kinzler(Johns Hopkins University), Sorin Alexandrescu(Institutul Clinic Fundeni), Bert Vogelstein(Johns Hopkins University), Alfredo Guglielmi(University of Verona), Noushin Niknafs(Johns Hopkins University), Mirte Mayke Streppel(Johns Hopkins University), Paola Capelli(University of Verona), Ralph H. Hruban(Johns Hopkins University), Pedram Argani(Johns Hopkins University), Aldo Scarpa(University of Verona)
Nature Genetics
November 3, 2013
Cited by 709


Related Papers